MX2010003571A - Composicion para el control de las reacciones catalizadas por lipasas. - Google Patents

Composicion para el control de las reacciones catalizadas por lipasas.

Info

Publication number
MX2010003571A
MX2010003571A MX2010003571A MX2010003571A MX2010003571A MX 2010003571 A MX2010003571 A MX 2010003571A MX 2010003571 A MX2010003571 A MX 2010003571A MX 2010003571 A MX2010003571 A MX 2010003571A MX 2010003571 A MX2010003571 A MX 2010003571A
Authority
MX
Mexico
Prior art keywords
composition
present
surfactant
interface
relates
Prior art date
Application number
MX2010003571A
Other languages
English (en)
Inventor
Pedro Miguel Neves Garcia Da Silva Reis
Martin Leser
Heribert Johann Watzke
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2010003571A publication Critical patent/MX2010003571A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invenci?n se refiere al campo de la lip?lisis mediada por lipasas. En particular, la presente invenci?n se refiere a la modulaci?n de la actividad de la lipasa por regulaci?n de la composici?n de la interface entre una fase hidrof?bica e hidrof?lica. M?s concretamente la presente invenci?n se refiere a la utilizaci?n de una formulaci?n que incluye al menos un surfactante con una presi?n interfacial que es lo suficientemente alta para controlar el acceso de los sustratos de la lipasa a la interface entre una fase lipof?lica y una fase hidrof?lica para regular la lip?lisis y una composici?n que comprende al menos un aceite y enriquecida con al menos un surfactante en la que el surfactante no es cortable por al menos una lipasa, tiene una mayor afinidad con la interface entre la fase hidrof?lica y lipof?lica que el al menos un l?pido y est? presente en una raz?n de peso para al menos un l?pido de alrededor de 1:1000 - 100:1.
MX2010003571A 2007-10-01 2008-10-01 Composicion para el control de las reacciones catalizadas por lipasas. MX2010003571A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07117649A EP2044930A1 (en) 2007-10-01 2007-10-01 Composition for controlling lipase catalyzed reactions
PCT/EP2008/063161 WO2009043879A1 (en) 2007-10-01 2008-10-01 Composition for controlling lipase catalyzed reactions

Publications (1)

Publication Number Publication Date
MX2010003571A true MX2010003571A (es) 2010-04-21

Family

ID=38926375

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003571A MX2010003571A (es) 2007-10-01 2008-10-01 Composicion para el control de las reacciones catalizadas por lipasas.

Country Status (11)

Country Link
US (1) US20110129504A1 (es)
EP (2) EP2044930A1 (es)
JP (1) JP2010540502A (es)
CN (1) CN101868226B (es)
AU (1) AU2008306960A1 (es)
BR (1) BRPI0817938A2 (es)
CL (1) CL2008002933A1 (es)
HK (1) HK1150230A1 (es)
MX (1) MX2010003571A (es)
RU (1) RU2491057C2 (es)
WO (1) WO2009043879A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201107630D0 (en) 2011-05-06 2011-06-22 Proxima Concepts Ltd Microemulsions
WO2013015288A1 (ja) * 2011-07-26 2013-01-31 ナガセケムテックス株式会社 リパーゼ活性阻害剤
CN104498545B (zh) * 2014-12-08 2017-11-14 广州嘉德乐生化科技有限公司 一种三聚甘油酯的制备方法
CN104642570A (zh) * 2015-03-11 2015-05-27 重庆第二师范学院 一种玉米胚芽油的改性制备方法
CN104719619B (zh) * 2015-04-21 2017-11-21 重庆威士化工有限公司 一种降低颗粒饲料制粒能耗的饲料添加剂及方法
BR112018072064B8 (pt) * 2016-05-20 2022-08-23 Nestec Sa Uso de triglicerídeos de cadeia média para preparação de composições nutricionais para proteção cardíaca em animais de estimação
US10716761B2 (en) 2017-07-24 2020-07-21 Alcresta Therapeutics, Inc. Ingestible medical delivery devices

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5843385B2 (ja) * 1979-07-24 1983-09-27 淳一 岩村 シジミの薬効成分及びその製造法
US5104858A (en) * 1988-09-29 1992-04-14 Yale University Sensitizing multidrug resistant cells to antitumor agents
US5104656A (en) * 1989-06-16 1992-04-14 Seth Pyare L Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent
JP3098561B2 (ja) * 1991-03-28 2000-10-16 花王株式会社 血清トリグリセリド濃度低下剤
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP4761093B2 (ja) * 1997-12-10 2011-08-31 シクロスポリン セラポイティクス リミテッド オメガ−３脂肪酸油を含む医薬組成物
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
JP4612930B2 (ja) * 2000-04-19 2011-01-12 花王株式会社 レムナント様リポタンパク低下剤
US20020103139A1 (en) * 2000-12-01 2002-08-01 M. Weisspapir Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control
JP2002322052A (ja) * 2001-04-26 2002-11-08 Kao Corp 小腸上皮中の脂質代謝改善剤
DE10247399A1 (de) * 2002-10-08 2004-04-29 Schering Ag Pharmazeutische Zubereitungen, Verwendung dieser Zubereitung und Verfahren zur Erhöhung der Bioverfügbarkeit von peroral zu applizierenden Arzneistoffen
CN1997282A (zh) * 2004-03-11 2007-07-11 马萨诸塞州立大学 脂质系统的生物聚合物包封和稳定性及其应用方法

Also Published As

Publication number Publication date
AU2008306960A1 (en) 2009-04-09
WO2009043879A1 (en) 2009-04-09
JP2010540502A (ja) 2010-12-24
RU2491057C2 (ru) 2013-08-27
BRPI0817938A2 (pt) 2015-05-05
HK1150230A1 (en) 2011-11-11
RU2010117234A (ru) 2011-11-10
CN101868226B (zh) 2012-07-04
EP2044930A1 (en) 2009-04-08
EP2205216A1 (en) 2010-07-14
US20110129504A1 (en) 2011-06-02
CN101868226A (zh) 2010-10-20
CL2008002933A1 (es) 2009-10-16

Similar Documents

Publication Publication Date Title
MX2010003571A (es) Composicion para el control de las reacciones catalizadas por lipasas.
GB2469003A (en) Primary side control circuit and method for ultra-low idle power operation
WO2007109330A3 (en) S1p receptor modulating compounds
AU2016219644A1 (en) Polyvalent RNA-Nanoparticle Compositions
WO2007092432A3 (en) Liquid-filled nanodroplets for anti-cancer therapy
WO2008030949A3 (en) Stable polyunsaturated fatty acid emulsions and methods for inhibitintg, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
MY157705A (en) Emulsified fats and oils composition
BR122017018225A8 (pt) Composição fungicida, seus usos, agente fungicida, método para controlar fungos nocivos fitopatogênicos, e semente resistente a fungos nocivos fitopatogênicos
UA90440C2 (ru) Инсектицидная или акарицидная композиция бифентрина и цианопиретроидов, способ борьбы с нежелательными насекомыми или клещами
NZ600403A (en) Enzymatic wound debriding compositions with enhanced enzymatic activity
MX2010008618A (es) Concentrados en supension basados en aceite.
TW200617173A (en) Process for production of microbial fat/oil containing discretional amount of diacylglycerol and said fat/oil
UA100689C2 (en) Herbicidal composition
WO2009123575A8 (en) A photosensitising composition and its uses
WO2009031099A3 (en) Cosmetic use of microorganisms
EP2073836A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES USING ENZYMES PRODUCING PEROXIDE AND PEROXIDASES
WO2008039472A3 (en) Stabilizing compositions for antibiotics and methods of use
CA2749967A1 (en) Medicament for the treatment of pain and inflammation
MX2007004231A (es) Ciertas plantas con concentraciones de acidos grasos "no saturados" o saturados reducidos en semillas y aceite derivado de las semillas._.
Irisa et al. Reduction of nitric oxide catalyzed by hydroxylamine oxidoreductase from an anammox bacterium
Filotheou et al. Application of response surface methodology to improve carotene production from synthetic medium by Blakeslea trispora in submerged fermentation
MX2010002405A (es) Composicion plaguicida y metodo para eliminar plagas.
EP1250917A3 (de) Mittel zur Bekämpfung von Mikroorganismen, enthaltend primäre und sekundäre Ester des Polyglycerins in einem wirksamen Verhältnis
WO2009035046A1 (ja) カビ処理剤及びカビ処理方法
GEP20135820B (en) Polyunsaturated fatty acid and diol ester as anti-acne agent

Legal Events

Date Code Title Description
FA Abandonment or withdrawal